2seventy bio Statistics Share Statistics 2seventy bio has 53.23M
shares outstanding. The number of shares has increased by 3.36%
in one year.
Shares Outstanding 53.23M Shares Change (YoY) 3.36% Shares Change (QoQ) 1.7% Owned by Institutions (%) 88.71% Shares Floating 42.7M Failed to Deliver (FTD) Shares 172,755 FTD / Avg. Volume 11.81%
Short Selling Information The latest short interest is 2.59M, so 4.87% of the outstanding
shares have been sold short.
Short Interest 2.59M Short % of Shares Out 4.87% Short % of Float 5.07% Short Ratio (days to cover) 4.4
Valuation Ratios The PE ratio is -2.68 and the forward
PE ratio is -33.33.
2seventy bio's PEG ratio is
0.04.
PE Ratio -2.68 Forward PE -33.33 PS Ratio 4.05 Forward PS 3.5 PB Ratio 0.73 P/FCF Ratio -1.79 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for 2seventy bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.67,
with a Debt / Equity ratio of 1.16.
Current Ratio 4.67 Quick Ratio 4.67 Debt / Equity 1.16 Debt / EBITDA -2.48 Debt / FCF -2.84 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $582.49K Profits Per Employee $-880.72K Employee Count 65 Asset Turnover 0.08 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 18.48% in the
last 52 weeks. The beta is 1.05, so 2seventy bio's
price volatility has been higher than the market average.
Beta 1.05 52-Week Price Change 18.48% 50-Day Moving Average 4.97 200-Day Moving Average 4.08 Relative Strength Index (RSI) 72.25 Average Volume (20 Days) 1,462,258
Income Statement In the last 12 months, 2seventy bio had revenue of 37.86M
and earned -57.25M
in profits. Earnings per share was -1.1.
Revenue 37.86M Gross Profit 15.3M Operating Income -115.43M Net Income -57.25M EBITDA -98.45M EBIT -105.54M Earnings Per Share (EPS) -1.1
Full Income Statement Balance Sheet The company has 71.24M in cash and 243.72M in
debt, giving a net cash position of -172.47M.
Cash & Cash Equivalents 71.24M Total Debt 243.72M Net Cash -172.47M Retained Earnings -568.46M Total Assets 480M Working Capital 157.19M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -85M
and capital expenditures -707K, giving a free cash flow of -85.7M.
Operating Cash Flow -85M Capital Expenditures -707K Free Cash Flow -85.7M FCF Per Share -1.64
Full Cash Flow Statement Margins Gross margin is 40.41%, with operating and profit margins of -304.87% and -151.2%.
Gross Margin 40.41% Operating Margin -304.87% Pretax Margin -151.2% Profit Margin -151.2% EBITDA Margin -260.01% EBIT Margin -304.87% FCF Margin -226.36%
